Skip to main content

US ClosedU.S. Closed

COAG: Hemab Therapeutics Holdings, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders.

52W Range

67thpctl

Volume

0.71×avg

Market Cap

2.09BUSD

P/E Ratio

-34.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Hemab Therapeutics Holdings, Inc. Common Stock

COAGNASDAQ Global Market·USD·Closed

Hemab Therapeutics Holdings, Inc. Common Stock

COAGNASDAQ·USD·Closed

$44.84

−9.40%

$44.84

−$4.65 (9.40%)

52W Range

67thpctl

Volume

0.71×avg

Mkt Cap

2.09BUSD

P/E

-34.2TTM

Div Yield

–ann